•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A00109 Summary:

BILL NOA00109B
 
SAME ASSAME AS S00320-B
 
SPONSORRosenthal L
 
COSPNSRForrest, Seawright, Aubry, Bichotte Hermelyn, Clark, Carroll, Hevesi, Simon, Jackson, Mitaynes, Reyes, Gonzalez-Rojas, Cruz, Epstein, Otis, Gallagher, Cunningham, Solages, Raga, Shimsky, Levenberg, Burdick, Tapia, Dinowitz, Weprin, Davila
 
MLTSPNSR
 
Add 2509-b, Pub Health L
 
Prohibits drug, cannabis or alcohol testing and screening of pregnant or postpartum individuals and newborns unless the individual consents and it is within the scope of medical care, or the testing or screening is necessary for a medical emergency.
Go to top    

A00109 Actions:

BILL NOA00109B
 
01/04/2023referred to health
05/19/2023amend and recommit to health
05/19/2023print number 109a
05/23/2023reported referred to codes
05/31/2023reported referred to rules
06/07/2023amend (t) and recommit to rules
06/07/2023print number 109b
01/03/2024referred to codes
03/19/2024reported
03/21/2024advanced to third reading cal.360
Go to top

A00109 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A109B
 
SPONSOR: Rosenthal L
  TITLE OF BILL: An act to amend the public health law, in relation to prohibiting drug, cannabis or alcohol testing and screening of pregnant or postpartum individuals and newborns   PURPOSE: This bill preserves the trust between a pregnant or perinatal person and their healthcare provider by requiring informed consent before conduct- ing a drug, cannabis or alcohol test or screen.   SUMMARY OF SPECIFIC PROVISIONS: Section one amends the public health law by adding a new section 2509-b. Section two establishes the effective date   JUSTIFICATION: When a pregnant person comes to a hospital seeking medical care, there is an expectation that they will receive only services to which they consent and seek. The involuntary drug testing of pregnant and perinatal persons not only runs counter to this, but it serves as a disincentive to the pursuit of medical support in childbirth. New York State current- ly ranks 30th among all states with a maternal mortality rate at 25 deaths per 100,000 live births. In cases where a doctor deems it necessary to perform an emergency test on an incapacitated patient, unable to consent to such testing, it is equally vital that the results of this testing be kept confidential and not used for any purpose outside of medical diagnoses and treatment. This legislation requires physicians and other medical professionals to seek informed consent before performing a drug, cannabis or alcohol test or screen on a pregnant person, a person up to one year postpartum or a newborn, unless such testing is necessary for emergency purposes. This legislation will help to preserve the necessary trust between a pregnant or perinatal person in need of medical support, and their provider, and will remove a potential disincentive to seeking care.   LEGISLATIVE HISTORY: 2021-22: A.4285-A - Ordered to Third Reading Rules; S.4821-A - Referred to Women's Issues 2019-20: A.5478-A - Referred to Governmental Operations; S.7955 - Referred to Women's Issues   FISCAL IMPLICATIONS: Undetermined.   EFFECTIVE DATE: This act shall take effect immediately.
Go to top

A00109 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         109--B
 
                               2023-2024 Regular Sessions
 
                   IN ASSEMBLY
 
                                       (Prefiled)
 
                                     January 4, 2023
                                       ___________
 
        Introduced   by  M.  of  A.  L. ROSENTHAL,  FORREST,  SEAWRIGHT,  AUBRY,
          BICHOTTE HERMELYN, CLARK, ZINERMAN, CARROLL, HEVESI,  SIMON,  JACKSON,
          MITAYNES,  REYES,  GONZALEZ-ROJAS, JEAN-PIERRE, BURGOS, CRUZ, EPSTEIN,
          OTIS, GALLAGHER, CUNNINGHAM, SOLAGES, RAGA -- read once  and  referred
          to  the  Committee  on  Health  -- committee discharged, bill amended,
          ordered reprinted as amended and  recommitted  to  said  committee  --
          reported  and  referred  to  the  Committee  on  Codes -- reported and
          referred to the Committee on Rules -- Rules Committee discharged, bill
          amended, ordered reprinted as amended and recommitted to the Committee
          on Rules
 
        AN ACT to amend the public health law, in relation to prohibiting  drug,
          cannabis  or  alcohol  testing and screening of pregnant or postpartum
          individuals and newborns
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  The  public health law is amended by adding a new section
     2  2509-b to read as follows:
     3    § 2509-b. Drug, cannabis or alcohol testing and screening for pregnant
     4  or postpartum individuals; prohibited. 1.  For purposes of this section:
     5    (a) "drug" shall mean a controlled substance as that term  is  defined
     6  in section thirty-three hundred six of this chapter.
     7    (b)  "cannabis"  shall mean cannabis or concentrated cannabis as those
     8  terms are defined in section 222.00 of the penal law.
     9    (c) "drug, cannabis or alcohol test" shall mean a test using a biolog-
    10  ical sample, including, but not limited to, urine or hair, for the pres-
    11  ence of drugs, cannabis or alcohol.
    12    (d) "drug, cannabis or alcohol screen" shall mean the use of  a  vali-
    13  dated  verbal  or written tool or questionnaire by a health care profes-
    14  sional licensed, certified, or  authorized  under  title  eight  of  the

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00489-04-3

        A. 109--B                           2
 
     1  education  law to determine use of drugs, cannabis or alcohol by a preg-
     2  nant or postpartum person.
     3    2.  No  health  care  professional  licensed, certified, or authorized
     4  under title eight of the education law shall:
     5    (a) perform a drug, cannabis or alcohol test on a person who is  preg-
     6  nant or up to one year postpartum unless:
     7    (i) the pregnant or postpartum individual gives prior written and oral
     8  informed consent specific to the drug, cannabis or alcohol test; and
     9    (ii)  the  performance of the drug, cannabis or alcohol test is within
    10  the scope of medical care being provided to the individual, cannabis.
    11    (b) perform a drug, cannabis or alcohol screen  in  a  hospital  on  a
    12  person who is pregnant or up to one year postpartum unless:
    13    (i)  the    pregnant or postpartum individual gives prior written  and
    14  oral informed consent specific to the drug, cannabis or alcohol  screen;
    15  and
    16    (ii)   the   performance   of  the drug, cannabis or alcohol screen is
    17  within the scope of medical care  being  provided  to the individual.
    18    (c) perform a drug, cannabis or alcohol screen outside a hospital on a
    19  person who is pregnant or up to one year postpartum unless:
    20    (i) the  pregnant or postpartum individual gives prior  oral  informed
    21  consent specific to the drug, cannabis or alcohol screen; and
    22    (ii)   the   performance   of  the drug, cannabis or alcohol screen is
    23  within the scope of medical  care  being  provided  to the individual.
    24    3. No health care professional licensed, certified or authorized under
    25  title eight of the education law shall:
    26    (a) perform a drug, cannabis or alcohol test on a newborn unless:
    27    (i) the individual authorized to consent for the newborn,  as  defined
    28  by  subdivision  two  of section twenty-five hundred four of this title,
    29  gives prior written and oral informed  consent  specific  to  the  drug,
    30  cannabis or alcohol test; and
    31    (ii)  the  performance of the drug, cannabis or alcohol test is within
    32  the scope of medical care being provided to the newborn;
    33    (b) perform a drug, cannabis or alcohol screen  in  a  hospital  on  a
    34  newborn unless:
    35    (i)  the    individual   authorized   to   consent for the newborn, as
    36  defined by subdivision two of section twenty-five hundred four  of  this
    37  title,  gives  prior   written and oral informed consent specific to the
    38  drug, cannabis or alcohol screen; and
    39    (ii)  the  performance  of  the drug, cannabis or  alcohol  screen  is
    40  within the scope of medical care  being  provided  to the newborn;
    41    (c) perform a drug, cannabis or alcohol screen outside a hospital on a
    42  newborn unless:
    43    (i)  the    individual   authorized   to   consent for the newborn, as
    44  defined by subdivision two of section twenty-five hundred four  of  this
    45  title, gives prior  oral informed consent specific to the drug, cannabis
    46  or alcohol screen; and
    47    (ii)   the   performance   of  the drug, cannabis or alcohol screen is
    48  within the scope of medical care  being  provided  to the newborn.
    49    4. Written and oral informed consent to a drug,  cannabis  or  alcohol
    50  test  or  drug  or alcohol screen shall occur at the time of testing, in
    51  language understandable to the pregnant or postpartum individual, or the
    52  individual authorized to consent for the  newborn,  under  circumstances
    53  that  provide such individual sufficient opportunity to consider whether
    54  or not to authorize the drug, cannabis or alcohol test or drug, cannabis
    55  or alcohol screen and minimize the  possibility  of  coercion  or  undue

        A. 109--B                           3
 
     1  influence,  and shall consist of oral authorization and written authori-
     2  zation that is dated, signed and includes the following:
     3    (a)  a  statement  explaining  that  consenting to a drug, cannabis or
     4  alcohol test or drug,  cannabis  or  alcohol  screen  is  voluntary  and
     5  requires written and oral informed consent, except when conditions under
     6  subdivision five of this section are met;
     7    (b) a statement that testing or screening positive for drugs, cannabis
     8  or alcohol could have legal consequences, including, but not limited to,
     9  a report to a local child protective services agency, and that the indi-
    10  vidual may want to consult with legal counsel prior to or after consent-
    11  ing  to  a  drug,  cannabis or alcohol test or drug, cannabis or alcohol
    12  screen;
    13    (c) a statement explaining the extent of confidentiality of  the  test
    14  or screen results;
    15    (d) a statement of the medical purpose of the test or screen; and
    16    (e) a general description of the test or screen.
    17    5.  Drug,  cannabis  or  alcohol  testing or drug, cannabis or alcohol
    18  screening may be performed without consent of the patient or  the  indi-
    19  vidual  authorized  to  consent  for  a newborn when, in the health care
    20  professional's judgment, an emergency exists and the patient or  newborn
    21  is  in  immediate  need  of  medical attention, and an attempt to secure
    22  consent would result in delay of treatment that could increase the  risk
    23  to  the  patient's  or  newborn's life or health. In the case that drug,
    24  cannabis or alcohol testing or drug or alcohol  screening  is  performed
    25  under these circumstances, the test or screen results shall be discussed
    26  with  the  patient  or  the  individual  authorized  to  consent for the
    27  newborn, in  language  understandable  to  the  patient  or  individuals
    28  authorized  to consent for the newborn and shall consist of oral notifi-
    29  cation and written notification that is dated, signed and  includes  the
    30  following:
    31    (a) a statement that testing or screening positive for drugs, cannabis
    32  or alcohol could have legal consequences, including but not limited to a
    33  potential  report  to a local child protective services agency, and that
    34  the patient or individual authorized to consent for the newborn may want
    35  to consult with legal counsel;
    36    (b) a statement in the medical record with a description of the  emer-
    37  gency that necessitated unconsented drug, cannabis or alcohol testing or
    38  drug, cannabis or alcohol screening; and
    39    (c)  a  statement explaining the extent of confidentiality of the test
    40  or screen results.
    41    6. No health care  professional  licensed,  certified,  or  authorized
    42  under title eight of the education law shall refuse to treat an individ-
    43  ual who is pregnant or up to one year postpartum or a newborn because of
    44  the  patient  or  individuals  authorized  to  consent for the newborn's
    45  refusal to submit to a drug, cannabis or alcohol test or drug,  cannabis
    46  or alcohol screen.
    47    7.  Nothing  in  this  section shall diminish any other requirement to
    48  obtain informed consent for a drug, cannabis or alcohol  test  or  drug,
    49  cannabis or alcohol screen or any other procedure.
    50    § 2. This act shall take effect immediately.
Go to top